Your browser doesn't support javascript.
loading
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer.
Mazzeschi, Martina; Sgarzi, Michela; Romaniello, Donatella; Gelfo, Valerio; Cavallo, Carola; Ambrosi, Francesca; Morselli, Alessandra; Miano, Carmen; Laprovitera, Noemi; Girone, Cinzia; Ferracin, Manuela; Santi, Spartaco; Rihawi, Karim; Ardizzoni, Andrea; Fiorentino, Michelangelo; D'Uva, Gabriele; Gyorffy, Balázs; Palmer, Ruth; Lauriola, Mattia.
Afiliação
  • Mazzeschi M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Sgarzi M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Romaniello D; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Gelfo V; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Cavallo C; Laboratory of Preclinical Studies for Regenerative Medicine of the Musculoskeletal System (RAMSES), (IRCCS) Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Ambrosi F; Pathology Unit, Maggiore Hospital, AUSL Bologna, Bologna, Italy.
  • Morselli A; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Miano C; National Laboratory of Molecular Biology and Stem Cell Engineering, National Institute of Biostructures and Biosystems (INBB), Bologna, Italy.
  • Laprovitera N; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Girone C; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Ferracin M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Santi S; Institute of Molecular Genetics, National Research Council of Italy, Bologna, Italy.
  • Rihawi K; IRCCS-Institute Orthopaedic Rizzoli, Bologna, Italy.
  • Ardizzoni A; Medical Oncology, IRCSS Azienda-Ospedaliero Universitaria di Bologna, Via Albertoni 15, 40138, Bologna, Italy.
  • Fiorentino M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • D'Uva G; Medical Oncology, IRCSS Azienda-Ospedaliero Universitaria di Bologna, Via Albertoni 15, 40138, Bologna, Italy.
  • Gyorffy B; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Palmer R; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.
  • Lauriola M; National Laboratory of Molecular Biology and Stem Cell Engineering, National Institute of Biostructures and Biosystems (INBB), Bologna, Italy.
J Exp Clin Cancer Res ; 41(1): 113, 2022 Mar 29.
Article em En | MEDLINE | ID: mdl-35351152
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citocinas / Neoplasias do Colo / Quinase do Linfoma Anaplásico Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Citocinas / Neoplasias do Colo / Quinase do Linfoma Anaplásico Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article